The Patent Finder

Terms ending in 2033

Biogen Idec MA Inc.

Every in-force patent on Biogen Idec MA Inc.'s record whose computed term ends in 2033, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 9,676,849Enhancement of Transport of Therapeutic Molecules Across the Blood Brain Barrier
In force
 · High confidence
Biogen MA Inc.In forceHigh confidence
US 11,286,528Methods of Reducing Immunogenicity Against Factor VIII in Individuals Undergoing Factor VIII Therapy
In force
 · High confidence
Bioverativ Therapeutics Inc.In forceHigh confidence
US 9,233,107Compositions and Methods for the Treatment of Progressive Multifocal Leukoencephalopathy (PML)
In force
 · High confidence
Biogen MA Inc.In forceHigh confidence
US 9,567,391JCV Neutralizing Antibodies
In force
 · High confidence
Biogen MA Inc.In forceHigh confidence
US 9,567,392JCV Neutralizing Antibodies
In force
 · High confidence
Biogen MA Inc.In forceHigh confidence
US 9,562,252Methods of Preventing and Removing Trisulfide Bonds
In force
 · High confidence
Biogen MA Inc.In forceHigh confidence
US 10,421,798Factor VIII Compositions and Methods of Making and Using Same
In force
 · High confidence
Bioverativ Therapeutics Inc.In forceHigh confidence
US 9,738,707Heterodimeric FC Regions, Binding Molecules Comprising Same, and Methods Relating Thereto
In force
 · High confidence
Biogen MA Inc.In forceHigh confidence
US 10,618,887Pyrimidinyl Tyrosine Kinase Inhibitors
In force
 · High confidence
Viracta Therapeutics, Inc.In forceHigh confidence
US 10,023,628Cell Line Expressing Single Chain Factor VIII Polypeptides and Uses Thereof
In force
 · High confidence
Bioverativ Therapeutics Inc.In forceHigh confidence
3 more term ends in 2033 · Pro
10 of 13 patents shown. Soonest term end first, then patent number.
Pro members see all 13.
Upgrade to Pro
2 of these are in force and held by Biogen Idec MA Inc..
Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited